Cargando…
A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy
BACKGROUND: Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder and is one of the most common muscular dystrophies. There are currently few effective therapies to treat the disease, although many small-molecule approaches are being pursued. Certain histone deacetylase inhibitors (HD...
Autores principales: | Farr, Gist H., Morris, Melanie, Gomez, Arianna, Pham, Thao, Kilroy, Elisabeth, Parker, Elizabeth U., Said, Shery, Henry, Clarissa, Maves, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559456/ https://www.ncbi.nlm.nih.gov/pubmed/33059738 http://dx.doi.org/10.1186/s13395-020-00251-4 |
Ejemplares similares
-
The HDAC Inhibitor TSA Ameliorates a Zebrafish Model of Duchenne Muscular Dystrophy
por: Johnson, Nathan M., et al.
Publicado: (2013) -
Beneficial impacts of neuromuscular electrical stimulation on muscle structure and function in the zebrafish model of Duchenne muscular dystrophy
por: Kilroy, Elisabeth A, et al.
Publicado: (2022) -
Influenza A Virus Infection Damages Zebrafish Skeletal Muscle and Exacerbates Disease in Zebrafish Modeling Duchenne Muscular Dystrophy
por: Goody, Michelle, et al.
Publicado: (2017) -
Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy
por: Rugowska, Anna, et al.
Publicado: (2021) -
Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)